Weite Beijing

Beijing Weite Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacture, and commercialization of chemical drugs, with a core focus on cardiovascular, cerebrovascular, and digestive system therapies. As a key subsidiary of China Grand Pharmaceutical and Healthcare Holdings (Grandpharma), the company is best known for its Alprostadil-based products, which are used to treat peripheral vascular disorders and improve microcirculation. Beijing Weite operates GMP-certified manufacturing facilities in Beijing and serves as a vital production hub for Grandpharma's internal medicine and vascular intervention portfolios. The company's product line includes both injectable and oral formulations, supported by an extensive distribution network across mainland China. Since its acquisition, it has been integrated into the parent group's broader strategy of expanding its footprint in chronic disease management.